» Articles » PMID: 32145716

[The Preliminary Analysis on the Characteristics of the Cluster for the COVID-19]

Overview
Date 2020 Mar 9
PMID 32145716
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Since December 2019, COVID-19, a new emerging infection disease, has spread in 27 countries and regions. The clusters of many cases were reported with the epidemic progresses. We collected currently available information for 377 COVID-19 clusters (1 719 cases), excluded the hospital clusters and Hubei cases, during the period from January 1 to February 20, 2020. There were 297 family clusters (79%), case median was 4; 39 clusters of dining (10%), case median was 5; 23 clusters of shopping malls or supermarkets (6%), case median was 13; 12 clusters of work units (3%), case median was 6, and 6 clusters of transportation. We selected 325 cases to estimate the incubation period and its range was 1 to 20 days, median was 7 days, and mode was 4 days. The analysis of the epidemic situation in a department store in China indicated that there was a possibility of patients as the source of infection during the incubation period of the epidemic. From February 5 to 21, 2020, 634 persons were infected on the Diamond Princess Liner. All persons are susceptible to the 2019 coronavirus. Age, patients during the incubation period and the worse environment might be the cause of the cases rising. The progress of the two typical outbreaks clearly demonstrated the spread of the early cases in Wuhan. In conclusion, screening and isolating close contacts remained essential other than clinical treatment during the epidemic. Especially for the healthy people in the epidemic area, isolation was the key.

Citing Articles

Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 Strains: A Systematic Review and Meta-analysis.

Wu Y, Kang L, Guo Z, Liu J, Liu M, Liang W JAMA Netw Open. 2022; 5(8):e2228008.

PMID: 35994285 PMC: 9396366. DOI: 10.1001/jamanetworkopen.2022.28008.


Presymptomatic, asymptomatic and post-symptomatic transmission of SARS-CoV-2: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance.

Mugglestone M, Ratnaraja N, Bak A, Islam J, Wilson J, Bostock J BMC Infect Dis. 2022; 22(1):453.

PMID: 35549902 PMC: 9096060. DOI: 10.1186/s12879-022-07440-0.


Epidemiological Characteristics and Transmissibility for SARS-CoV-2 of Population Level and Cluster Level in a Chinese City.

Yu S, Cui S, Rui J, Zhao Z, Deng B, Liu C Front Public Health. 2022; 9:799536.

PMID: 35118044 PMC: 8805998. DOI: 10.3389/fpubh.2021.799536.


Chronicles from the new normal: Urban planning, mobility and land-use management in the face of the COVID-19 crisis.

Corazza M, Moretti L, Forestieri G, Galiano G Transp Res Interdiscip Perspect. 2021; 12:100503.

PMID: 34849483 PMC: 8616577. DOI: 10.1016/j.trip.2021.100503.


A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage.

Ishay Y, Potruch A, Schwartz A, Berg M, Jamil K, Agus S Biomed Pharmacother. 2021; 143:112228.

PMID: 34649354 PMC: 8455249. DOI: 10.1016/j.biopha.2021.112228.